Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

Tragedy Strikes at Canadian Overdose Prevention Center Despite Staff Efforts

by October 8, 2024
October 8, 2024
Tragedy Strikes at Canadian Overdose Prevention Center Despite Staff Efforts

Jeffrey A. Singer

Last week, the staff at an overdose prevention center (OPC) in London, Ontario were unable to save a client who overdosed on a drug consumed at the facility, even after they rushed the person to a nearby hospital for further resuscitation. Harm reduction opponents have already begun pointing to the event as an argument against Canada’s 38 OPCs.

The coroner’s report and toxicology results are not yet available, so it is important not to jump to conclusions. We don’t yet know what substances contaminated the drug the deceased obtained on the black market. It is possible there were other substances in addition to or in place of fentanyl that rendered naloxone less effective as a reversal agent. For example, an increasing number of toxicology studies are finding another synthetic opioid, isotonitazene or “iso,” which can be ten times more powerful than fentanyl, present in the victim’s system. In late 2023, British law enforcement reported a big influx of this class of opioids called nitazenes had entered the illicit drug market in the UK.

Regardless of what the report ultimately reveals, it is important to maintain perspective. No medical treatment is perfect. The operative word in the term harm reduction is “reduction.” In a 2023 Cato briefing paper, I reviewed the worldwide experience with OPCs, initially called “safe consumption sites.” The oldest legally sanctioned OPC has been operating in Bern, Switzerland since 1986. The paper concluded:

OPCs have a more-than-30-year track record of preventing overdose deaths, HIV and hepatitis, and other diseases, and of helping people with substance use disorder find treatment. As of August 2022, 147 OPCs are providing services in 91 communities in 16 countries. They continue to gain acceptance as an effective tool for reducing the dangers of using drugs obtained through the increasingly deadly black market.

My research at the time found no report of any overdose deaths from any of the 147 OPCs. Eighteen months after the first two OPCs in the US opened in New York City, OnPointNYC, the harm reduction organization operating them, reported that it reversed 1,008 overdoses with no fatalities at its centers.

However, it was never realistic to believe that staff at OPCs would be able to resuscitate every overdose. As Dr. Gillian Golla of the University of Victoria’s Canadian Institute for Substance Use Research told CTV News reporters about the unsuccessful resuscitation at the Canadian OPC:

“…we don’t expect absolute perfection from other parts of the healthcare system. We don’t expect emergency departments to save every single person who walks in their doors.

“As someone who has worked in a supervised consumption site, there are frequently very complex overdoses that occur, and this is happening more frequently as the toxic mix of unregulated fentanyl gets more worse. This emphasizes the need for easily-accessible harm reduction services.”

A May 2022 study found that bystanders successfully reversed 95 percent of overdoses with naloxone nasal spray—usually from illicit fentanyl—but they often needed to administer multiple doses because of fentanyl’s potency. Another study by researchers at Brigham and Women’s Hospital in Boston found that 6.3 percent of overdose victims whom Emergency Medical Technicians (EMTs) attempted to save with naloxone died on the same day.

While it is wrong to claim that overdose deaths are completely prevented at OPCs, it remains the case that they are exceedingly rare.

Just as it would be unreasonable to close emergency rooms for not being able to save every patient, it would be similarly unreasonable to abandon overdose prevention centers for not being able to reverse every overdose. 

0
FacebookTwitterGoogle +Pinterest
previous post
Mike Lee outlines roadmap for McConnell successor, warns the ‘health of the Republican Party’ is at stake
next post
Biden White House has ‘very low’ trust in Netanyahu regime, urges transparency: report

You may also like

The Xylazine Scourge Widens

July 17, 2024

Dolton, Illinois’s Governance Crisis Has Wider Implications

April 22, 2024

Withdrawing from the WHO: A Chance to Rethink...

January 22, 2025

Grace-Marie Turner, RIP

June 3, 2025

Trade Policies of Both Parties Ignore What Most...

September 4, 2024

Friday Feature: Taking Charge of Your Children’s Education

May 12, 2023

Gender Board Quotas: Still Unhelpful to Working Women

September 7, 2023

Diamond, Dybvig, and Government Deposit Insurance

November 25, 2022

Brazil’s Judicial Authoritarians Ban X, Punish Their Citizens,...

September 4, 2024

Vivek Ramaswamy’s Conditions for Allowing Elections

August 30, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Good Riddance to the Penny

      June 5, 2025
    • Oracle Fusion Testing: The UK Leader’s Playbook for Automation

      June 5, 2025
    • Blue state Republicans threaten rebellion if Senate changes key provision in Trump’s ‘big, beautiful bill’

      June 5, 2025
    • Ricketts, Fetterman team up for crackdown on China’s attempts to purchase US farmland

      June 5, 2025
    • Hamas working to ‘sabotage’ Trump-backed aid group with ‘fake news’: Israeli official

      June 5, 2025
    • Longtime Trump loyalist flips on GOP’s ‘big, beautiful bill’

      June 5, 2025

    Categories

    • Business (8,148)
    • Investing (2,009)
    • Politics (15,529)
    • Stocks (3,128)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved